# Baldwin Insurance Group, Inc.: financial statements, quarterly

BWIN · Nasdaq · CIK 1781755 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bwin.md) · [Financials](/companies/bwin/financials.md) · [Filings](/companies/bwin/filings.md) · [Insiders](/companies/bwin/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bwin/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [304](/filings/0001781755-24-000093.md) | [283 d](/filings/0001781755-26-000018.md) | [378](/filings/0001781755-25-000063.md) | [337](/filings/0001781755-25-000096.md) | [335](/filings/0001781755-25-000109.md) | [327 d](/filings/0001781755-26-000018.md) | [411](/filings/0001781755-26-000034.md) | [376](/filings/0001781755-26-000049.md) | [362](/filings/0001781755-25-000109.md) | [345 d](/filings/0001781755-26-000018.md) | [529](/filings/0001781755-26-000034.md) | [489](/filings/0001781755-26-000049.md) |
| Operating income | $m | [0.1](/filings/0001781755-24-000093.md) | [(29.7) d](/filings/0001781755-26-000018.md) | [34.3](/filings/0001781755-25-000063.md) | [16.5](/filings/0001781755-25-000096.md) | [15.4](/filings/0001781755-25-000109.md) | [(5.5) d](/filings/0001781755-26-000018.md) | [56.0](/filings/0001781755-26-000034.md) | [27.9](/filings/0001781755-26-000049.md) | [3.2](/filings/0001781755-25-000109.md) | [(13.2) d](/filings/0001781755-26-000018.md) | [(101)](/filings/0001781755-26-000034.md) | [(8.3)](/filings/0001781755-26-000049.md) |
| Income tax | $m | [0.2](/filings/0001781755-24-000093.md) | [0.4 d](/filings/0001781755-26-000018.md) | [0.7](/filings/0001781755-25-000063.md) | [1.5](/filings/0001781755-25-000096.md) | [0.0](/filings/0001781755-25-000109.md) | [(0.4) d](/filings/0001781755-26-000018.md) | [0.0](/filings/0001781755-26-000034.md) | [0.7](/filings/0001781755-26-000049.md) | [0.0](/filings/0001781755-25-000109.md) | [1.0 d](/filings/0001781755-26-000018.md) | [(145)](/filings/0001781755-26-000034.md) | [0.1](/filings/0001781755-26-000049.md) |
| Net income | $m | [(17.6)](/filings/0001781755-24-000093.md) | [(34.5) d](/filings/0001781755-26-000018.md) | [21.6](/filings/0001781755-25-000063.md) | [(17.6)](/filings/0001781755-25-000096.md) | [(8.4)](/filings/0001781755-25-000109.md) | [(20.2) d](/filings/0001781755-26-000018.md) | [13.9](/filings/0001781755-26-000034.md) | [(3.2)](/filings/0001781755-26-000049.md) | [(18.7)](/filings/0001781755-25-000109.md) | [(25.9) d](/filings/0001781755-26-000018.md) | [2.3](/filings/0001781755-26-000034.md) | [(39.0)](/filings/0001781755-26-000049.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001781755-24-000093.md) | not reported | [0.33](/filings/0001781755-25-000063.md) | [(0.28)](/filings/0001781755-25-000096.md) | [(0.13)](/filings/0001781755-25-000109.md) | not reported | [0.20](/filings/0001781755-26-000034.md) | [(0.05)](/filings/0001781755-26-000049.md) | [(0.27)](/filings/0001781755-25-000109.md) | not reported | [0.02](/filings/0001781755-26-000034.md) | [(0.42)](/filings/0001781755-26-000049.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0001781755-24-000093.md) | not reported | [0.35](/filings/0001781755-25-000063.md) | [(0.28)](/filings/0001781755-25-000096.md) | [(0.13)](/filings/0001781755-25-000109.md) | not reported | [0.21](/filings/0001781755-26-000034.md) | [(0.05)](/filings/0001781755-26-000049.md) | [(0.27)](/filings/0001781755-25-000109.md) | not reported | [0.02](/filings/0001781755-26-000034.md) | [(0.42)](/filings/0001781755-26-000049.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [79.0](/filings/0001781755-23-000042.md) | [116](/filings/0001781755-25-000017.md) | [112](/filings/0001781755-24-000030.md) | [208](/filings/0001781755-24-000048.md) | [182](/filings/0001781755-24-000093.md) | [90.0](/filings/0001781755-26-000018.md) | [81.8](/filings/0001781755-25-000063.md) | [106](/filings/0001781755-25-000096.md) | [89.7](/filings/0001781755-25-000109.md) | [124](/filings/0001781755-26-000049.md) | [146](/filings/0001781755-26-000034.md) | [184](/filings/0001781755-26-000049.md) |
| Current assets | $m | [802](/filings/0001781755-23-000042.md) | [926](/filings/0001781755-25-000017.md) | [951](/filings/0001781755-24-000030.md) | [1,137](/filings/0001781755-24-000048.md) | [1,014](/filings/0001781755-24-000093.md) | [1,026](/filings/0001781755-26-000018.md) | [1,056](/filings/0001781755-25-000063.md) | [1,240](/filings/0001781755-25-000096.md) | [1,106](/filings/0001781755-25-000109.md) | [1,200](/filings/0001781755-26-000049.md) | [1,594](/filings/0001781755-26-000034.md) | [1,846](/filings/0001781755-26-000049.md) |
| Total assets | $m | [3,423](/filings/0001781755-23-000042.md) | [3,502](/filings/0001781755-25-000017.md) | [3,510](/filings/0001781755-24-000030.md) | [3,680](/filings/0001781755-24-000048.md) | [3,539](/filings/0001781755-24-000093.md) | [3,535](/filings/0001781755-26-000018.md) | [3,549](/filings/0001781755-25-000063.md) | [3,739](/filings/0001781755-25-000096.md) | [3,794](/filings/0001781755-25-000109.md) | [3,862](/filings/0001781755-26-000049.md) | [5,943](/filings/0001781755-26-000034.md) | [6,175](/filings/0001781755-26-000049.md) |
| Current liabilities | $m | [798](/filings/0001781755-23-000042.md) | [1,033](/filings/0001781755-25-000017.md) | [1,053](/filings/0001781755-24-000030.md) | [1,156](/filings/0001781755-24-000048.md) | [1,032](/filings/0001781755-24-000093.md) | [1,056](/filings/0001781755-26-000018.md) | [933](/filings/0001781755-25-000063.md) | [1,007](/filings/0001781755-25-000096.md) | [960](/filings/0001781755-25-000109.md) | [1,033](/filings/0001781755-26-000049.md) | [1,474](/filings/0001781755-26-000034.md) | [1,721](/filings/0001781755-26-000049.md) |
| Total liabilities | $m | [2,350](/filings/0001781755-23-000042.md) | [2,483](/filings/0001781755-25-000017.md) | [2,438](/filings/0001781755-24-000030.md) | [2,637](/filings/0001781755-24-000048.md) | [2,502](/filings/0001781755-24-000093.md) | [2,526](/filings/0001781755-26-000018.md) | [2,500](/filings/0001781755-25-000063.md) | [2,689](/filings/0001781755-25-000096.md) | [2,666](/filings/0001781755-25-000109.md) | [2,778](/filings/0001781755-26-000049.md) | [4,391](/filings/0001781755-26-000034.md) | [4,753](/filings/0001781755-26-000049.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [10.2](/filings/0001781755-23-000042.md) | [10.2](/filings/0001781755-25-000017.md) | [10.2](/filings/0001781755-24-000030.md) | [8.4](/filings/0001781755-24-000048.md) | [8.4](/filings/0001781755-24-000093.md) | [8.4](/filings/0001781755-26-000018.md) | [9.4](/filings/0001781755-25-000063.md) | [9.4](/filings/0001781755-25-000096.md) | [10.1](/filings/0001781755-25-000109.md) | [12.6](/filings/0001781755-26-000049.md) | [16.1](/filings/0001781755-26-000034.md) | [16.1](/filings/0001781755-26-000049.md) |
| Shareholders' equity | $m | [591](/filings/0001781755-23-000042.md) | [560](/filings/0001781755-25-000017.md) | [598](/filings/0001781755-24-000030.md) | [591](/filings/0001781755-24-000048.md) | [595](/filings/0001781755-24-000093.md) | [583](/filings/0001781755-26-000018.md) | [620](/filings/0001781755-25-000063.md) | [631](/filings/0001781755-25-000096.md) | [620](/filings/0001781755-25-000109.md) | [600](/filings/0001781755-26-000049.md) | [964](/filings/0001781755-26-000034.md) | [884](/filings/0001781755-26-000049.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(12.6) d](/filings/0001781755-24-000093.md) | [(22.8) d](/filings/0001781755-26-000018.md) | [3.0](/filings/0001781755-25-000063.md) | [18.3 d](/filings/0001781755-25-000096.md) | [32.4 d](/filings/0001781755-25-000109.md) | [(2.3) d](/filings/0001781755-26-000018.md) | [(64.0)](/filings/0001781755-26-000034.md) | [(16.7) d](/filings/0001781755-26-000049.md) | [41.0 d](/filings/0001781755-25-000109.md) | [10.3 d](/filings/0001781755-26-000018.md) | [(6.1)](/filings/0001781755-26-000034.md) | [45.6 d](/filings/0001781755-26-000049.md) |
| Capital expenditure | $m | [5.5 d](/filings/0001781755-23-000042.md) | [7.2 d](/filings/0001781755-24-000016.md) | [8.1](/filings/0001781755-24-000030.md) | [10.6 d](/filings/0001781755-24-000048.md) | [10.2 d](/filings/0001781755-25-000109.md) | [12.2 d](/filings/0001781755-26-000018.md) | [8.9](/filings/0001781755-26-000034.md) | [11.4 d](/filings/0001781755-26-000049.md) | [8.9 d](/filings/0001781755-25-000109.md) | [10.4 d](/filings/0001781755-26-000018.md) | [12.7](/filings/0001781755-26-000034.md) | [15.2 d](/filings/0001781755-26-000049.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001781755-26-000034.md) | [0.0 d](/filings/0001781755-26-000049.md) | not reported | not reported | [47.0](/filings/0001781755-26-000034.md) | [79.9 d](/filings/0001781755-26-000049.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.3](/filings/0001781755-23-000042.md) | [58.7](/filings/0001781755-24-000030.md) | [60.1](/filings/0001781755-24-000048.md) | [60.5](/filings/0001781755-24-000093.md) | [65.3](/filings/0001781755-25-000063.md) | [63.1](/filings/0001781755-25-000096.md) | [64.0](/filings/0001781755-25-000109.md) | [69.3](/filings/0001781755-26-000034.md) | [68.0](/filings/0001781755-26-000049.md) | [68.6](/filings/0001781755-25-000109.md) | [96.8](/filings/0001781755-26-000034.md) | [92.8](/filings/0001781755-26-000049.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,988,164 at 2020-11-06, from the cover of the [10-Q filed 2020-11-12](/filings/0001781755-20-000076.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.